Applied Therapeutics Inc (APLT NASDAQ) stock market data APIs
$0.3232
-0.01(-3.1%)
as of July 1, 2025
Try our APIs with
free plan!
Applied Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Prev. Close
0.3232
Open
0.3093
High
0.3306
Low
0.3044
52 wk Range
0.295-10.6237
Market Cap
45 304 K
Shares Outstanding
142 M
Revenue
265 K
EPS
0.3281
Beta
1.874
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Applied Therapeutics Inc data using free add-ons & libraries
Get Applied Therapeutics Inc Fundamental Data
Applied Therapeutics Inc Fundamental data includes:
- Net Revenue: 265 K
- EBITDA: -108 730 752
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: -0.185
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Applied Therapeutics Inc News
New
Applied Therapeutics promotes two executives to leadership roles
NEW YORK - Applied Therapeutics, Inc. (NASDAQ:APLT), a biopharmaceutical company with a market capitalization of approximately $50 million, announced on Tuesday the promotion of Evan Bailey, MD, to Ch...
Applied Therapeutics Announces Key Leadership Appointments
Evan Bailey, MD, promoted to Chief Medical Officer, succeeding Riccardo Perfetti, MD, PhDDottie Caplan promoted to Executive Vice President, Patient Advocacy and Government Affairs NEW YORK, June 17...
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute...
Applied Therapeutics Reports First Quarter 2025 Financial Results
- Company to present full 12-month clinical data and new topline 18-month and 24-month data from INSPIRE registrational Phase 3 trial of govorestat in CMT-SORD Deficiency at the Peripheral Nerve Socie...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
